What Happened? Shares of dental products company Dentsply Sirona (NASDAQ:XRAY) fell 6.8% in the afternoon session after the company reported second-quarter 2...
DENTSPLY SIRONA (NASDAQ:XRAY) reported second-quarter 2026 revenue of $898 million, down 4.1% on a reported basis and 6.3% on a constant-currency basis, as the dental products company continued its turnaround plan amid lower volumes in several businesses and distributor inventory reductions in Europ
Dental products company Dentsply Sirona (NASDAQ:XRAY) reported Q2 CY2026 results topping the market’s revenue expectations, but sales fell by 4.1% year on ye...
Dental products company Dentsply Sirona (NASDAQ:XRAY) will be reporting results this Thursday after market hours. Here’s what investors should know. Dentsply...
Dentsply Sirona has been treading water for the past six months, recording a small loss of 0.5% while holding steady at $12.66. The stock also fell short of ...
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the dental equipment & technology stocks, including Dentsply Sirona (NASDAQ:XRAY) and i...
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv...
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc...
What Happened? A number of stocks fell in the afternoon session after the April PPI report showed wholesale inflation accelerating to 6% annually, with servi...
Dentsply Sirona’s first quarter results reflected a company in the midst of operational transformation, with revenue holding steady year over year but outper...
Dental products company Dentsply Sirona (NASDAQ:XRAY) reported Q1 CY2026 results beating Wall Street’s revenue expectations, but sales were flat year on year...
Dental products company Dentsply Sirona (NASDAQ:XRAY) announced better-than-expected revenue in Q1 CY2026, but sales were flat year on year at $880 million. ...
Dental products company Dentsply Sirona (NASDAQ:XRAY) will be reporting results this Tuesday after the bell. Here’s what investors should know. Dentsply Siro...
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how dental equipment ...
What Happened? A number of stocks jumped in the afternoon session as the reopening of the Strait of Hormuz signaled a cooling of global logistics and energy ...
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv...
Although the S&P 500 is down 3.2% over the past six months, Dentsply Sirona’s stock price has fallen further to $11.47, losing shareholders 9.6% of their cap...
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
